David Givol

21.4k total citations · 4 hit papers
262 papers, 18.0k citations indexed

About

David Givol is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, David Givol has authored 262 papers receiving a total of 18.0k indexed citations (citations by other indexed papers that have themselves been cited), including 201 papers in Molecular Biology, 94 papers in Radiology, Nuclear Medicine and Imaging and 68 papers in Oncology. Recurrent topics in David Givol's work include Monoclonal and Polyclonal Antibodies Research (93 papers), Glycosylation and Glycoproteins Research (56 papers) and Cancer-related Molecular Pathways (34 papers). David Givol is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (93 papers), Glycosylation and Glycoproteins Research (56 papers) and Cancer-related Molecular Pathways (34 papers). David Givol collaborates with scholars based in Israel, United States and United Kingdom. David Givol's co-authors include Gideon Rechavi, Avner Yayon, Moshe Oren, Yosef Yarden, Peter Lonai, Sima Lev, Joseph Schlessinger, Eytan Domany, Ninette Amariglio and Avi Orr‐Urtreger and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

David Givol

261 papers receiving 16.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Induction of WAF1/CIP1 by a p53-independent pathway.

1994 699 citations David Givol et al. PubMed profile →
Participation of p53 cellular tumour antigen in transformation of normal embryonic cells

1984 617 citations David Givol et al. profile →
Outcome signature genes in breast cancer: is there a unique set?

2004 580 citations Liat Ein‐Dor, Itai Kela et al. Bioinformatics profile →
Sequence of chicken ovalbumin mRNA

1978 384 citations David Givol et al. profile →

Peers

Countries citing papers authored by David Givol

Since Specialization

Citations

This map shows the geographic impact of David Givol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Givol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Givol more than expected).

Fields of papers citing papers by David Givol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Givol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Givol. The network helps show where David Givol may publish in the future.

Co-authorship network of co-authors of David Givol

This figure shows the co-authorship network connecting the top 25 collaborators of David Givol. A scholar is included among the top collaborators of David Givol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Givol. David Givol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs 2011 ·Cell Cycle ·Rosa Puca, Lavinia Nardinocchi, Manuela Porru, Anthony Simon, Gideon Rechavi, Carlo Leonetti, David Givol, Gabriella D’Orazi	100
2	Counteracting MDM2‐induced HIPK2 downregulation restores HIPK2/p53 apoptotic signaling in cancer cells 2010 ·FEBS Letters ·Lavinia Nardinocchi, Rosa Puca, David Givol, Gabriella D’Orazi	12
3	Zinc Downregulates HIF-1α and Inhibits Its Activity in Tumor Cells In Vitro and In Vivo 2010 ·PLoS ONE ·Lavinia Nardinocchi, (unknown), Rosa Puca, Manuela Porru, Aurora Aiello, Annalisa Grasselli, Carlo Leonetti, Michal Safran, Gideon Rechavi, David Givol, Antonella Farsetti, Gabriella D’Orazi	101
4	Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells 2010 ·Oncogene ·Rosa Puca, Lavinia Nardinocchi, David Givol, Gabriella D’Orazi	120
5	Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis 2010 ·Free Radical Biology and Medicine ·Rosa Puca, Lavinia Nardinocchi, Giuseppe Starace, Gideon Rechavi, Ada Sacchi, David Givol, Gabriella D’Orazi	64
6	Reversible Dysfunction of Wild-Type p53 following Homeodomain-Interacting Protein Kinase-2 Knockdown 2008 ·Cancer Research ·Rosa Puca, Lavinia Nardinocchi, Hilah Gal, Gideon Rechavi, Ninette Amariglio, Eytan Domany, Daniel A. Notterman, Marco Scarsella, Carlo Leonetti, Ada Sacchi, Giovanni Blandino, David Givol, Gabriella D’Orazi	62
7	FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway 2008 ·Human Molecular Genetics ·Takehiko Matsushita, William R. Wilcox, (unknown), Aya Kawanami, Hülya Bükülmez, Gener Balmes, Pavel Krejčı́, Pertchoui B. Mekikian, (unknown), Isakichi Yamaura, Matthew L. Warman, David Givol, Shunichi Murakami	115
8	Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells 2006 ·Leukemia ·Hilah Gal, Ninette Amariglio, L. Trakhtenbrot, (unknown), Ofer Margalit, Abraham Avigdor, Arnon Nagler, Sigal Tavor, Liat Ein‐Dor, Tsvee Lapidot, Eytan Domany, Gideon Rechavi, David Givol	108
9	Outcome signature genes in breast cancer: is there a unique set? breakdown → 2004 ·Bioinformatics ·Liat Ein‐Dor, Itai Kela, Gad Getz, David Givol, Eytan Domany	580
10	DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1 2001 ·Oncogene ·Karuppiah Kannan, Naftali Kaminski, Gideon Rechavi, (unknown), Ninette Amariglio, David Givol	127
11	Overexpression of p21waf1/cip1 arrests the growth of chicken embryo fibroblasts that overexpress E2F1 1998 ·Oncogene ·I Givol, David Givol, Stephen H. Hughes	10
12	The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction 1995 ·Cell ·Janna Blechman, Sima Lev, Jacob Barg, Miriam Eisenstein, (unknown), Zvi Vogel, David Givol, Yosef Yarden	142
13	Steel Factor and c-kit Protooncogene: Genetic Lessons in Signal Transduction 1994 ·Critical Reviews™ in Oncogenesis ·Sima Lev, Janna Blechman, David Givol, Yosef Yarden	91
14	Flg-2, a new member of the family of fibroblast growth factor receptors. 1991 ·PubMed ·A. Avivi, Yitzhak Zimmer, Avner Yayon, Yosef Yarden, David Givol	49
15	Domain deletion in the extracellular portion of the EGF-receptor reduces ligand binding and impairs cell surface expression. 1990 ·PubMed ·Irit Lax, F. Bellot, Annemarie Honegger, Albrecht Schmidt, A Ullrich, David Givol, Joseph Schlessinger	23
16	Immunoglobulin heavy chain gene rearrangements in chronic lymphocytic leukaemia: correlation with clinical stage 1989 ·British Journal of Haematology ·G Rechavi, Mathilda Mandel, Nurit Katzir, F. Brok‐Simoni, I. Hakim, (unknown), Miriam Biniaminov, David Givol, Isaac Ben‐Bassat, Bracha Ramot	15
17	Chicken Epidermal Growth Factor (EGF) Receptor: cDNA Cloning, Expression in Mouse Cells, and Differential Binding of EGF and Transforming Growth Factor Alpha 1988 ·Molecular and Cellular Biology ·Irit Lax, Ann Johnson, R. Howk, John Sap, F. Bellot, M. Winkler, A Ullrich, Björn Vennström, Joseph Schlessinger, David Givol	48
18	Efficient In Vitro and In Vivo Expression of Human Glucocerebrosidase cDNA 1987 ·DNA ·Orly Reiner, Sylvia Wilder, David Givol, Mia Horowitz	29
19	Human HER2 ( neu ) Promoter: Evidence for Multiple Mechanisms for Transcriptional Initiation 1987 ·Molecular and Cellular Biology ·Michael Tal, C. Richter King, M H Kraus, Axel Ullrich, Joseph Schlessinger, David Givol	29
20	Combining site and antigenic determinants of the V regions. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·David Givol, (unknown), Rina Zakut, Yinon Ben‐Neriah, Peter Lonai	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact